<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Despite mounting evidence that epigenetic abnormalities play a key role in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> biology, their contributions to the malignant phenotype remain poorly understood </plain></SENT>
<SENT sid="1" pm="."><plain>Here we studied genome-wide DNA methylation in <z:mpath ids='MPATH_458'>normal</z:mpath> B-cell populations and subtypes of B-cell non-Hodgkin <z:hpo ids='HP_0002665'>lymphoma</z:hpo>: follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>These <z:hpo ids='HP_0002665'>lymphomas</z:hpo> display striking and progressive intra-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> and also inter-patient <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in their <z:chebi fb="1" ids="16040">cytosine</z:chebi> methylation patterns </plain></SENT>
<SENT sid="3" pm="."><plain>Epigenetic <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> is initiated in <z:mpath ids='MPATH_458'>normal</z:mpath> germinal center B-cells, increases markedly with disease <z:hpo ids='HP_0000718'>aggressiveness</z:hpo>, and is associated with unfavorable clinical outcome </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, patterns of abnormal methylation vary depending upon chromosomal regions, gene density and the status of neighboring genes </plain></SENT>
<SENT sid="5" pm="."><plain>DNA methylation abnormalities arise via two distinct processes: i) lymphomagenic transcriptional regulators perturb promoter DNA methylation in a target gene-specific manner, and ii) aberrant epigenetic states tend to spread to neighboring promoters in the absence of CTCF insulator binding sites </plain></SENT>
</text></document>